A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
Conditions: Cerebrovascular Accident; Spasticity, Post-Stroke Interventions: Drug: Botulinum toxin type A; Drug: placebo Sponsor: GlaxoSmithKline Completed - verified July 2011